riley mccormack
CIK 1536534 · Chief Executive Officer · last filed 2026-05-21
riley mccormack is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for DMRC, was dated May 21, 2026. Across all open-market trades the lifetime net is +$1.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $43.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$43.03M
2
12
$1.66M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DMRC | Chief Executive Officer | 3,804,899 | $11.31 | $43.03M | $732.5K | 9 | 2026-05-21 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 2,325,000 | $28.80 | $66.96M | $929.0K | 3 | 2015-01-16 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-21 | DMRC | Mixed | — | $0 | EDGAR |
| 2026-05-20 | DMRC | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | DMRC | Grant (A) | +18,160 | $637.6K | EDGAR |
| 2023-02-17 | DMRC | Grant (A) | +1,309 | $29.3K | EDGAR |
| 2022-03-10 | DMRC | Buy (P) | +30,000 | $732.5K | EDGAR |
| 2021-06-28 | DMRC | Grant (A) | +8,644 | $0 | EDGAR |
| 2021-04-14 | DMRC | Grant (A) | +8,644 | $0 | EDGAR |
| 2020-12-15 | DMRC | Conv (C) | +3,594,483 | $51.65M | EDGAR |
| 2020-10-30 | DMRC | Grant (A) | +6,546 | $0 | EDGAR |
| 2015-01-16 | Oruka Therapeutics, Inc. (ABIO) Delisted | Sell (S) | −350,000 | -$267.5K | EDGAR |